Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
{{output}}
The present study was designed to identify the changes in microvesicle-dipeptidyl peptidase-IV (DPP IV) levels in human urine and serum, and to determine whether there were correlations with the severity of diabetic kidney disease (DKD). A total of 127 patient... ...
